Chemical formula: C₁₆H₂₅GdN₄O₈ Molecular mass: 558.65 g/mol PubChem compound: 158536
Gadoteric acid has paramagnetic properties allowing MRI contrast enhancement. It has no specific pharmacodynamic activity and is biologically very inert.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08CA02 | Gadoteric acid | V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DOTAREM Solution for injection | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |
Gadoteric acid is an active ingredient of these brands:
Austria (AT)Brazil (BR)
Canada (CA)
Croatia (HR)Cyprus (CY)Estonia (EE)France (FR)Ireland (IE)Japan (JP)
Lithuania (LT)Poland (PL)Romania (RO)Spain (ES)Tunisia (TN)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
